株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の薬剤溶出ステント市場 - 世界の業界分析、規模、シェア、成長、動向、予測

Drug-eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

発行 Transparency Market Research 商品コード 912368
出版日 ページ情報 英文 256 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
世界の薬剤溶出ステント市場 - 世界の業界分析、規模、シェア、成長、動向、予測 Drug-eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日: 2019年09月09日 ページ情報: 英文 256 Pages
概要

当レポートでは、世界の薬剤溶出ステント市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場分析と予測

第5章 主な動向

  • 画期的技術
  • 法規制認可
  • 戦略的アプローチ
  • 製品上市

第6章 製品別市場分析と予測

  • イントロダクションと定義
  • 主な調査結果と動向
  • 市場価値予測
  • 市場の魅力度

第7章 薬剤別市場分析と予測

第8章 世代別市場分析と予測

第9章 スキャッフォールドタイプ別市場分析と予測

第10章 用途別市場分析と予測

第11章 エンドユーザー別市場分析と予測

第12章 地域別市場分析と予測

第13章 北米

第14章 欧州

第15章 アジア太平洋地域

第16章 ラテンアメリカ

第17章 中東・アフリカ

第18章 競合動向

  • 市場参入企業
  • 競合ビジネス戦略
  • 企業プロファイル
図表

List of Tables

  • Table 01 Regulatory Approvals in Drug-eluting Stents Market (1/2)
  • Table 02 Regulatory Approvals in Drug-eluting Stents Market (2/2)
  • Table 03 Product Launch in Drug-eluting Stents Market
  • Table 04 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 05 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 06 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 07 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 08 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 09 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 10 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 11 Global Drug-eluting Stents Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 12 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 13 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 14 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 15 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 16 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 17 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 18 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 19 North America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 20 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 21 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 22 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 23 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 24 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 25 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 26 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 27 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 28 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 29 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 30 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 31 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 32 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 33 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 34 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 35 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 36 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 37 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 38 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 39 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 40 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 41 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 42 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 43 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 44 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 45 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Polymer-based Type, 2017-2027
  • Table 46 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Drug, 2017-2027
  • Table 47 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Generation, 2017-2027
  • Table 48 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Scaffold, 2017-2027
  • Table 49 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Application, 2017-2027
  • Table 50 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 51 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 01 Strategic Approaches by Market Players (Acquisitions, Partnerships, and Distribution Agreements, etc.) in Drug-eluting Stents Market (1/2)
  • Figure 02 Strategic Approaches by Market Players (Acquisitions, Partnerships, and Distribution Agreements, etc.) in Drug-eluting Stents Market (2/2)
  • Figure 03 Global Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 04 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Polymer-based, 2017-2027
  • Figure 05 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Polymer-free, 2017-2027
  • Figure 06 Global Drug-eluting Stents Market Attractiveness, by Product, 2019-2027
  • Figure 07 Global Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 08 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Sirolimus, 2017-2027
  • Figure 09 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Everolimus, 2017-2027
  • Figure 10 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Paclitaxel, 2017-2027
  • Figure 11 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Zotarolimus, 2017-2027
  • Figure 12 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biolimus, 2017-2027
  • Figure 13 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
  • Figure 14 Global Drug-eluting Stents Market Attractiveness, by Drug, 2019-2027
  • Figure 15 Global Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 16 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 1st Generation, 2017-2027
  • Figure 17 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 2nd Generation, 2017-2027
  • Figure 18 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 3rd Generation, 2017-2027
  • Figure 19 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by 4th Generation, 2017-2027
  • Figure 20 Global Drug-eluting Stents Market Attractiveness, by Generation, 2019-2027
  • Figure 21 Global Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 22 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cobalt Chromium, 2017-2027
  • Figure 23 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Platinum Chromium, 2017-2027
  • Figure 24 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Nitinol, 2017-2027
  • Figure 25 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biodegradable, 2017-2027
  • Figure 26 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biolimus, 2017-2027
  • Figure 27 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2027
  • Figure 28 Global Drug-eluting Stents Market Attractiveness, by Scaffold, 2019-2027
  • Figure 29 Global Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 30 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Coronary Diseases, 2017-2027
  • Figure 31 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Vascular Diseases, 2017-2027
  • Figure 32 Global Drug-eluting Stents Market Attractiveness, by Application, 2019-2027
  • Figure 33 Global Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 34 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017-2027
  • Figure 35 Global Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017-2027
  • Figure 36 Global Drug-eluting Stents Market Attractiveness, by End User, 2019-2027
  • Figure 37 Global Drug-eluting Stents Market Value Share (%), by Region, 2018 and 2027
  • Figure 38 Global Drug-eluting Stents Market Attractiveness, by Region, 2019-2027
  • Figure 39 North America Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 40 North America Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 41 North America Drug-eluting Stents Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 42 North America Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 43 North America Drug-eluting Stents Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 44 North America Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 45 North America Drug-eluting Stents Market Attractiveness Analysis, by Generation, 2019-2027
  • Figure 46 North America Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 47 North America Drug-eluting Stents Market Attractiveness Analysis, by Scaffold, 2019-2027
  • Figure 48 North America Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 49 North America Drug-eluting Stents Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 50 North America Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 51 North America Drug-eluting Stents Market Attractiveness Analysis, by End User, 2019-2027
  • Figure 52 North America Drug-eluting Stents Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 53 North America Drug-eluting Stents Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 54 Europe Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 55 Europe Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 56 Europe Drug-eluting Stents Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 57 Europe Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 58 Europe Drug-eluting Stents Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 59 Europe Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 60 Europe Drug-eluting Stents Market Attractiveness Analysis, by Generation, 2019-2027
  • Figure 61 Europe Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 62 Europe Drug-eluting Stents Market Attractiveness Analysis, by Scaffold, 2019-2027
  • Figure 63 Europe Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 64 Europe Drug-eluting Stents Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 65 Europe Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 66 Europe Drug-eluting Stents Market Attractiveness Analysis, by End User, 2019-2027
  • Figure 67 Europe Drug-eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 68 Europe Drug-eluting Stents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 69 Asia Pacific Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 70 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 71 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 72 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 73 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 74 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 75 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Generation, 2019-2027
  • Figure 76 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 77 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Scaffold, 2019-2027
  • Figure 78 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 79 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 80 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 81 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by End User, 2019-2027
  • Figure 82 Asia Pacific Drug-eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 83 Asia Pacific Drug-eluting Stents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 84 Latin America Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 85 Latin America Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 86 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 87 Latin America Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 88 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 89 Latin America Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 90 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Generation, 2019-2027
  • Figure 91 Latin America Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 92 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Scaffold, 2019-2027
  • Figure 93 Latin America Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 94 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 95 Latin America Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 96 Latin America Drug-eluting Stents Market Attractiveness Analysis, by End User, 2019-2027
  • Figure 97 Latin America Drug-eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 98 Latin America Drug-eluting Stents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 99 Middle East & Africa Drug-eluting Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 100 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 101 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Product, 2019-2027
  • Figure 102 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Drug, 2018 and 2027
  • Figure 103 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Drug, 2019-2027
  • Figure 104 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Generation, 2018 and 2027
  • Figure 105 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Generation, 2019-2027
  • Figure 106 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Scaffold, 2018 and 2027
  • Figure 107 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Scaffold, 2019-2027
  • Figure 108 Figure 43: Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 109 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 110 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by End User, 2018 and 2027
  • Figure 111 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by End User, 2019-2027
  • Figure 112 Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 113 Middle East & Africa Drug-eluting Stents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
目次

Title:
Drug-eluting Stents Market (Product: Polymer-based and Polymer-free; Drug: Sirolimus, Everolimus, Paclitaxel, Zotarolimus, Biolimus, and Others; Generation: 1st Generation, 2nd Generation, 3rd Generation, and 4th Generation: Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, and Others; Application: Coronary Diseases and Peripheral Vascular Diseases; End User: Hospitals and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Scope of the Report

[256 Pages Report] The latest research from Transparency Market Research offers a perspective on the growth trajectory of drug-eluting stents market for the period of 2019-2027. The prime objective of this report is to provide insights and key dynamics pertaining to the drug-eluting stents market that are gradually helping reimagine its future development prospects.

Key growth indicators of the drug-eluting stents market, including historical value and volume analysis, pricing analysis, value and supply chain analysis, and Y-o-Y growth trend analysis have been elucidated in the report. Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.

TMR covers a detailed taxonomy of the drug-eluting stents market, along with an incisive outlook on the competitive scenario. The report profiles a list of companies operating in the drug-eluting stents market, wherein, the product portfolios, technological innovations, geographical expansion, and key growth strategies of these players have been mentioned in detail.

The report on the drug-eluting stents market allows stakeholders to understand key demand trends that end users may seek in the long run, and the appropriate sourcing strategy for the same. For companies involved in the drug-eluting stents market, the report helps understand key end users contributing to demand, allowing them to strategically formulate steps to enhance their sales prospects.

Key Questions Answered:

Elaborate insights provided in the drug-eluting stents market report address various questions to help stakeholders gain a deeper understanding and take critical decisions with confidence and clarity.

Some of these questions include:

  • What is the consumption rate of the products based on geographical division?
  • Which trends and barriers will impact the development and sizing of the drug-eluting stents market?
  • What growth momentum or acceleration does the drug-eluting stents market carry during the forecast period?
  • Which region may tap the highest market share in the next five years?
  • What focused approach and constraints are holding the drug-eluting stents market tight?
  • What are the general conditions prevailing and influencing the business environment of the drug-eluting stents market?
  • How have leading players in the drug-eluting stents market been able to maintain a distinct competitive edge over their competitors?

Research Methodology

The drug-eluting stents market report is a result of unique research methodology, which includes a perfect combination of primary research, secondary research, and expert panel reviews. The data repository for the drug-eluting stents market is updated on a continuous basis, with key stakeholders and their developments tracked at regular intervals.

Secondary sources such as annual reports, company websites, industry white papers, government publications, investor presentations, statistical databases, internal and external proprietary databases, and regulatory databases are generally referred to for developing preliminary market understanding.

Primary research involves interviews and e-mail interactions with C-level executives, KOLs, and regional officers of companies operating in the drug eluting stents market, for unbiased, yet detailed reviews on the drug-eluting stents market across different geographical divisions.

Information obtained from secondary resources and verified by primary resources have contributed to the compilation of the drug-eluting stents market report.

Segmentation

The report provides an all-inclusive segmental analysis of the global drug-eluting stents market, which has been classified into seven broader categories - product, drug, generation, scaffold, application, end user, and region.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug-eluting Stents Market

  • 3.1. Market Overview
  • 3.2. Introduction
  • 3.3. Product Definition
  • 3.4. Industry Evolution / Developments

4. Overview

  • 4.1. Market Dynamics
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Global Drug-eluting Stents Market Analysis and Forecast, 2017-2027

5. Key Insights

  • 5.1. Breakthrough Technologies in Drug-eluting Stents Market
  • 5.2. Regulatory Approvals in Drug-eluting Stents Market
  • 5.3. Strategic Approaches by Market Players (Acquisitions, Partnerships, and Distribution Agreements, etc.)
  • 5.4. Product Launch

6. Global Drug-eluting Stents Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 6.3.1. Polymer-based
      • 6.3.1.1. Biodegradable Polymers
      • 6.3.1.2. Durable Polymers
    • 6.3.2. Polymer-free
  • 6.4. Global Drug-eluting Stents Market Attractiveness, by Product

7. Global Drug-eluting Stents Market Analysis and Forecast, by Drug

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 7.3.1. Sirolimus
    • 7.3.2. Paclitaxel
    • 7.3.3. Zotarolimus
    • 7.3.4. Everolimus
    • 7.3.5. Biolimus
    • 7.3.6. Others
  • 7.4. Global Drug-eluting Stents Market Attractiveness, by Drug

8. Global Drug-eluting Stents Market Analysis and Forecast, by Generation

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 8.3.1. 1st Generation
    • 8.3.2. 2nd Generation
    • 8.3.3. 3rd Generation
    • 8.3.4. 4th Generation
  • 8.4. Market Attractiveness, by Generation

9. Global Drug-eluting Stents Market Analysis and Forecast, by Scaffold Type

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Global Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 9.3.1. Cobalt Chromium
    • 9.3.2. Platinum Chromium
    • 9.3.3. Nitinol
    • 9.3.4. Biodegradable
    • 9.3.5. Others
  • 9.4. Global Drug-eluting Stents Market Attractiveness, by Scaffold Type

10. Global Drug-eluting Stents Market Analysis and Forecast, by Application

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Global Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 10.3.1. Coronary Diseases
    • 10.3.2. Peripheral Vascular Diseases
  • 10.4. Global Drug-eluting Stents Market Attractiveness, by Application

11. Global Drug-eluting Stents Market Analysis and Forecast, by End-user

  • 11.1. Introduction & Definition
  • 11.2. Key Findings / Developments
  • 11.3. Global Drug-eluting Stents Market Value Forecast, by End-user, 2017-2027
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
  • 11.4. Global Drug-eluting Stents Market Attractiveness, by End-user

12. Global Drug-eluting Stents Market Analysis and Forecast, by Region

  • 12.1. Key Findings
  • 12.2. Global Drug-eluting Stents Market Value Forecast, by Region
    • 12.2.1. North America
    • 12.2.2. Europe
    • 12.2.3. Asia Pacific
    • 12.2.4. Latin America
    • 12.2.5. Middle East & Africa
  • 12.3. Global Drug-eluting Stents Market Attractiveness, by Country/Region

13. North America Drug-eluting Stents Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. North America Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 13.3.1. Polymer-based
      • 13.3.1.1. Biodegradable Polymers
      • 13.3.1.2. Durable Polymers
    • 13.3.2. Polymer-free
  • 13.4. North America Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 13.4.1. Sirolimus
    • 13.4.2. Paclitaxel
    • 13.4.3. Zotarolimus
    • 13.4.4. Everolimus
    • 13.4.5. Biolimus
    • 13.4.6. Others
  • 13.5. North America Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 13.5.1. 1st Generation
    • 13.5.2. 2nd Generation
    • 13.5.3. 3rd Generation
    • 13.5.4. 4th Generation
  • 13.6. North America Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 13.6.1. Cobalt Chromium
    • 13.6.2. Platinum Chromium
    • 13.6.3. Nitinol
    • 13.6.4. Biodegradable
    • 13.6.5. Others
  • 13.7. North America Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 13.7.1. Coronary Diseases
    • 13.7.2. Peripheral Vascular Diseases
  • 13.8. North America Drug-eluting Stents Market Value Forecast, by End-user, 2017-2027
    • 13.8.1. Hospitals
    • 13.8.2. Ambulatory Surgical Centers
  • 13.9. North America Drug-eluting Stents Market Value Forecast, by Country, 2017-2027
    • 13.9.1. 1. U.S.
    • 13.9.2. Canada
  • 13.10. North America Drug-eluting Stents Market Attractiveness Analysis
    • 13.10.1. By Product
    • 13.10.2. By Drug
    • 13.10.3. By Generation
    • 13.10.4. By Scaffold Type
    • 13.10.5. By Application
    • 13.10.6. By End-user
    • 13.10.7. By Country

14. Europe Drug-eluting Stents Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Europe Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 14.3.1. Polymer-based
      • 14.3.1.1. Biodegradable Polymers
      • 14.3.1.2. Durable Polymers
    • 14.3.2. Polymer-free
  • 14.4. Europe Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 14.4.1. Sirolimus
    • 14.4.2. Paclitaxel
    • 14.4.3. Zotarolimus
    • 14.4.4. Everolimus
    • 14.4.5. Biolimus
    • 14.4.6. Others
  • 14.5. Europe Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 14.5.1. 1st Generation
    • 14.5.2. 2nd Generation
    • 14.5.3. 3rd Generation
    • 14.5.4. 4th Generation
  • 14.6. Europe Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 14.6.1. Cobalt Chromium
    • 14.6.2. Platinum Chromium
    • 14.6.3. Nitinol
    • 14.6.4. Biodegradable
    • 14.6.5. Others
  • 14.7. Europe Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 14.7.1. Coronary Diseases
    • 14.7.2. Peripheral Vascular Diseases
  • 14.8. Europe Drug-eluting Stents Market Value Forecast, by End-user, 2017-2027
    • 14.8.1. Hospitals
    • 14.8.2. Ambulatory Surgical Centers
  • 14.9. Europe Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.9.1. Germany
    • 14.9.2. U.K.
    • 14.9.3. France
    • 14.9.4. Spain
    • 14.9.5. Italy
    • 14.9.6. Rest of Europe
  • 14.10. Europe Drug-eluting Stents Market Attractiveness Analysis
    • 14.10.1. By Product
    • 14.10.2. By Drug
    • 14.10.3. By Generation
    • 14.10.4. By Scaffold Type
    • 14.10.5. By Application
    • 14.10.6. By End-user
    • 14.10.7. By Country/Sub-region

15. Asia Pacific Drug-eluting Stents Market Analysis and Forecast

  • 15.1. Introduction
  • 15.2. Key Findings
  • 15.3. Asia Pacific Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 15.3.1. Polymer-based
      • 15.3.1.1. Biodegradable Polymers
      • 15.3.1.2. Durable Polymers
    • 15.3.2. Polymer-free
  • 15.4. Asia Pacific Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 15.4.1. Sirolimus
    • 15.4.2. Paclitaxel
    • 15.4.3. Zotarolimus
    • 15.4.4. Everolimus
    • 15.4.5. Biolimus
    • 15.4.6. Others
  • 15.5. Asia Pacific Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 15.5.1. 1st Generation
    • 15.5.2. 2nd Generation
    • 15.5.3. 3rd Generation
    • 15.5.4. 4th Generation
  • 15.6. Asia Pacific Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 15.6.1. Cobalt Chromium
    • 15.6.2. Platinum Chromium
    • 15.6.3. Nitinol
    • 15.6.4. Biodegradable
    • 15.6.5. Others
  • 15.7. Asia Pacific Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 15.7.1. Coronary Diseases
    • 15.7.2. Peripheral Vascular Diseases
  • 15.8. Asia Pacific Drug-eluting Stents Market Value Forecast, by End-user, 2017-2027
    • 15.8.1. Hospitals
    • 15.8.2. Ambulatory Surgical Centers
  • 15.9. Asia Pacific Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017-2027
    • 15.9.1. China
    • 15.9.2. Japan
    • 15.9.3. India
    • 15.9.4. Australia & New Zealand
    • 15.9.5. Rest of Asia Pacific
  • 15.10. Asia Pacific Drug-eluting Stents Market Attractiveness Analysis
    • 15.10.1. By Product
    • 15.10.2. By Drug
    • 15.10.3. 15.9By Generation
    • 15.10.4. By Scaffold Type
    • 15.10.5. By Application
    • 15.10.6. By End-user
    • 15.10.7. By Country/Sub-region

16. Latin America Drug-eluting Stents Market Analysis and Forecast

  • 16.1. Introduction
  • 16.2. Key Findings
  • 16.3. Latin America Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 16.3.1. Polymer-based
      • 16.3.1.1. Biodegradable Polymers
      • 16.3.1.2. Durable Polymers
    • 16.3.2. Polymer-free
  • 16.4. Latin America Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 16.4.1. Sirolimus
    • 16.4.2. Paclitaxel
    • 16.4.3. Zotarolimus
    • 16.4.4. Everolimus
    • 16.4.5. Biolimus
    • 16.4.6. Others
  • 16.5. Latin America Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 16.5.1. 1st Generation
    • 16.5.2. 2nd Generation
    • 16.5.3. 3rd Generation
    • 16.5.4. 4th Generation
  • 16.6. Latin America Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 16.6.1. Cobalt Chromium
    • 16.6.2. Platinum Chromium
    • 16.6.3. Nitinol
    • 16.6.4. Biodegradable
    • 16.6.5. Others
  • 16.7. Latin America Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 16.7.1. Coronary Diseases
    • 16.7.2. Peripheral Vascular Diseases
  • 16.8. Latin America Drug-eluting Stents Market Value Forecast, by End-user, 2017-2027
    • 16.8.1. Hospitals
    • 16.8.2. Ambulatory Surgical Centers
  • 16.9. Latin America Drug-eluting Stents Market Value Forecast, by Country/Sub-region, 2017-2027
    • 16.9.1. Brazil
    • 16.9.2. Mexico
    • 16.9.3. Rest of Latin America
  • 16.10. Latin America Drug-eluting Stents Market Attractiveness Analysis
    • 16.10.1. By Product
    • 16.10.2. By Drug
    • 16.10.3. By Generation
    • 16.10.4. By Scaffold Type
    • 16.10.5. By Application
    • 16.10.6. By End-user
    • 16.10.7. By Country/Sub-region

17. Middle East & Africa Drug-eluting Stents Market Analysis and Forecast

  • 17.1. Introduction
  • 17.2. Key Findings
  • 17.3. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Product, 2017-2027
    • 17.3.1. Polymer-based
      • 17.3.1.1. Biodegradable Polymers
      • 17.3.1.2. Durable Polymers
    • 17.3.2. Polymer-free
  • 17.4. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Drug, 2017-2027
    • 17.4.1. Sirolimus
    • 17.4.2. Paclitaxel
    • 17.4.3. Zotarolimus
    • 17.4.4. Everolimus
    • 17.4.5. Biolimus
    • 17.4.6. Others
  • 17.5. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Generation, 2017-2027
    • 17.5.1. 1st Generation
    • 17.5.2. 2nd Generation
    • 17.5.3. 3rd Generation
    • 17.5.4. 4th Generation
  • 17.6. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Scaffold Type, 2017-2027
    • 17.6.1. Cobalt Chromium
    • 17.6.2. Platinum Chromium
    • 17.6.3. Nitinol
    • 17.6.4. Biodegradable
    • 17.6.5. Others
  • 17.7. Middle East & Africa Drug-eluting Stents Market Value Forecast, by Application, 2017-2027
    • 17.7.1. Coronary Diseases
    • 17.7.2. Peripheral Vascular Diseases
  • 17.8. Market Value Forecast, by End-user, 2017-2027
    • 17.8.1. Hospitals
    • 17.8.2. Ambulatory Surgical Centers
  • 17.9. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 17.9.1. GCC Countries
    • 17.9.2. South Africa
    • 17.9.3. Rest of Middle East & Africa
  • 17.10. Middle East & Africa Drug-eluting Stents Market Attractiveness Analysis
    • 17.10.1. By Product
    • 17.10.2. By Drug
    • 17.10.3. By Generation
    • 17.10.4. By Scaffold Type
    • 17.10.5. By Application
    • 17.10.6. By End-user
    • 17.10.7. By Country/Sub-region

18. Competition Landscape

  • 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 18.2. Market Share Analysis by Company (2018)
  • 18.3. Company Profiles
    • 18.3.1. Boston Scientific Corporation
      • 18.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.1.2. Financial Overview
      • 18.3.1.3. Product Portfolio
      • 18.3.1.4. SWOT Analysis
      • 18.3.1.5. Strategic Overview
    • 18.3.2. Medtronic
      • 18.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.2.2. Financial Overview
      • 18.3.2.3. Product Portfolio
      • 18.3.2.4. SWOT Analysis
      • 18.3.2.5. Strategic Overview
    • 18.3.3. Abbott
      • 18.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.3.2. Financial Overview
      • 18.3.3.3. Product Portfolio
      • 18.3.3.4. SWOT Analysis
      • 18.3.3.5. Strategic Overview
    • 18.3.4. Biosensors International Group, Ltd (Bluesail Medical Co., Ltd.)
      • 18.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. SWOT Analysis
      • 18.3.4.4. Strategic Overview
    • 18.3.5. Biotronik
      • 18.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. SWOT Analysis
      • 18.3.5.4. Strategic Overview
    • 18.3.6. MicroPort Scientific Corporation
      • 18.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.6.2. Financial Overview
      • 18.3.6.3. Product Portfolio
      • 18.3.6.4. SWOT Analysis
      • 18.3.6.5. Strategic Overview
    • 18.3.7. Terumo Corporation
      • 18.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.7.2. Financial Overview
      • 18.3.7.3. Product Portfolio
      • 18.3.7.4. SWOT Analysis
      • 18.3.7.5. Strategic Overview
    • 18.3.8. Cook
      • 18.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.8.2. Product Portfolio
      • 18.3.8.3. SWOT Analysis
      • 18.3.8.4. Strategic Overview
    • 18.3.9. STENTYS SA
      • 18.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.9.2. Financial Overview
      • 18.3.9.3. Product Portfolio
      • 18.3.9.4. SWOT Analysis
      • 18.3.9.5. Strategic Overview
    • 18.3.10. Medinol Ltd
      • 18.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 18.3.10.2. Product Portfolio
      • 18.3.10.3. SWOT Analysis
      • 18.3.10.4. Strategic Overview
Back to Top